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Objectives. We reviewed the factors contributing to or causing
death before surgery in neonates with d-transposition of the great
arteries (TGA) despite anatomy suitable for the arterial switch
operation (ASO) to develop strategies to minimize preoperative
attrition.
Background. Currently the ASO for neonates with TGA carries
a low operative mortality. However, there is a paucity of informa-
tion regarding the patients who die before the ASO. Strategies to
ensure survival to operation are of importance to improve overall
outcome.
Methods. We reviewed all neonates with TGA and patent
forearm ovale (PFO) <22 mm, a birthweight <2 kg, or who died
before surgery, between 1988 and 1996.
Results. We identified 12 out of 295 neonates with TGA (4.1%)
with anatomy suitable for the ASO who died prior to surgery. All
had TGA/intact ventricular septum (IVS) and presented with a
severely restrictive PFO. In 11 of 12 cases the cause of death was
attributed to the sequelae of profound hypoxemia from inade-
quate mixing. Contributing factors were prematurity, 41.7%;
severe respiratory distress syndrome, 25%; and persistent pulmo-
nary hypertension of the newborn (PPHN), 16.7%. All patients
received prostaglandin E1 (PGE1) infusion. Urgent balloon atrial
sepstostomy (BAS) was performed in 66.7% with improved oxy-
genation. No cases were diagnosed prenatally. In contrast, all
patients with a PFO <2 2 mm who survived to ASO had a
significantly better response to PGE1 infusion (p 5 0.03) than
nonsurvivors. The ASO was accomplished without mortality in
four of nine with a weight <2 kg.
Conclusions. Of those neonates admitted with TGA, 4.1% died
before surgery. Eleven of 12 (3.7%) died due to consequences of
inadequate interatrial mixing despite PGE1 infusion. Earlier
diagnosis and BAS are critically important in determining sur-
vival. Early ASO may improve survival in patients weighing
<2 kg. Prenatal diagnosis with delivery in a high-risk obstetrical
unit with facilities for immediate BAS and supportive therapy for
pulmonary hypertension and ventricular failure may be necessary
to salvage this group of patients.
(J Am Coll Cardiol 1998;32:753–7)
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Transposition of the great arteries (TGA) is the most common
cyanotic congenital heart defect to present in the newborn
(1,2). Attrition without treatment is high and 50% of patients
die by the first month of life, especially if the ventricular
septum is intact (3). However, balloon atrial septostomy
(BAS), the Mustard and Senning procedures, and recently the
arterial switch operation (ASO) have changed the outcome
dramatically. Indeed, the evolution of the management of
TGA culminating in physiological and anatomical correction is
a paradigm of success in the treatment of complex congenital
heart disease. It was anticipated that the neonatal ASO would
overcome important disadvantages of the Mustard and Sen-
ning procedures, in particular death before operation, late
arrhythmia, and right ventricular failure (4–6). However,
examination of the causes and incidence of attrition in neo-
nates before the arterial switch have not been investigated.
Therefore, we reviewed retrospectively all neonates with TGA
who did not survive to undergo ASO to document the inci-
dence of, and define strategies to minimize, death before
operation. In addition, to assess the contribution of a small
patent foramen ovale (PFO) and low birthweight to early
preoperative death we reviewed the outcome of TGA with
either a PFO of #2 mm or a birthweight #2 kg.
Methods
We began to perform the arterial switch operation in
neonates with simple TGA routinely in 1988. We searched the
databases of cardiovascular surgery and cardiology of the
Toronto Hospital for Sick Children for all neonates admitted
between 1988 and 1996 with anatomy suitable for the arterial
switch operation. We excluded patients with important ventric-
ular hypoplasia that precluded biventricular repair, and severe
pulmonary stenosis or atresia. We analyzed all available clini-
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cal, echocardiographic, cardiac catheterization, angiographic,
and autopsy data.
We imaged the atrial septum by echocardiography from the
subcostal short axis view and measured the widest interatrial
communication during the cardiac cycle. We imaged the patent
ductus arteriosus (PDA) from the suprasternal or high
parasternal window and recorded the narrowest dimension
with on-line calipers and the direction of flow by Doppler
interrogation.
Pulmonary hypertension was diagnosed either by the pres-
ence of reverse differential cyanosis, or a ductal shunt predom-
inantly from pulmonary artery to aorta by echocardiography or
histologically at autopsy.
Statistical analysis. As the sample size was small and the
data not normally distributed the nonparametric Mann-
Whitney U test was used to compare differences between
patients who survived and those who died before surgery. A p
value of ,0.05 was considered significant.
Results
We admitted 295 neonates with TGA and anatomy suitable
for the arterial switch operation between 1988 and 1996.
Twelve patients (4.1%) died prior to surgery. Their perinatal
and postnatal data are summarized in Table 1.
Echocardiographic features. All 12 patients had TGA with
intact ventricular septum and severely restrictive foramen
ovale (0–2 mm). Obvious bowing of the interatrial septum
(IAS) into the right atrium was evident in nine of 12 patients.
We detected an aneurysm of the IAS in three of 12 and
reduced biventricular function in another three patients.
Response to prostaglandin PGE1. Eleven of 12 patients
received PGE1 at the referring institution, before the arrival of
the transport team, at the initial rate of 0.1 mg/kg/min but only
two responded with a rise in oxygen saturation of 10% or more.
One patient did not receive PGE1 until the arrival of the
transport team because it was unavailable at the referring
hospital.
Transportation. The median time between arrival of the
transport team at the referring hospital and admission to the
Hospital for Sick Children in Toronto was 3.5 h, with a range
of 2–6 hours.
Balloon atrial septostomy (BAS). Emergency BAS was
performed in eight of 12 patients (four of eight in the cardiac
catheterization laboratory and four of eight on the intensive
care unit under echocardiographic guidance). One patient
(patient 6), with a weight of 1740 g and respiratory distress
syndrome of prematurity, remained persistently desaturated
4 d after BAS. He was considered too small and premature for
an arterial switch at that time and underwent Blalock-Hanlon
septectomy. In all eight cases an adequate sized atrial commu-
nication was created, either by balloon or surgically, as judged
by oxygen saturation (.75%), echocardiogram, surgical in-
spection, and/or autopsy. Median atrial septal defect size was
8 mm (range 8–13 mm). There were no complications associ-
ated with BAS. Four patients died without BAS at median age
of 10 h (range 9–15 h). All four were admitted before we
performed BAS routinely on the intensive care unit. Two
Abbreviations and Acronyms
ASO 5 arterial switch operation
BAS 5 balloon atrial septostomy
IVS 5 intact ventricular septum
PDA 5 patent ductus arteriosus
PFO 5 patent foramen ovale
PGE1 5 prostaglandin E1
PPHN 5 persistent pulmonary hypertension of the newborn
TGA 5 d-transposition of the great arteries
VSD 5 ventricular septal defect



























1 3.8 37 7,7 20 6 5 1.2 3.2 18 h PPHN 5 d
2 3.1 38 5,5 40 8 3 1.3 3.7 N/D DIC, pulmonary hemorrhage 12 h
3 1.3 28 3,8 60 12 2 1.5 4.0 N/D Sepsis, seizure 15 h
4 3.8 37 8,3 50 5 5 1.5 3.5 13 h MAS, PPHN 4 d
5 1.4 32 8,8 70 9 4 1.3 2.2 17 h Tracheal stenosis 21 d
6 1.7 32 6,7 60 48 2 2.0 3.8 8 d RDS, NEC 14 d
7 3.7 39 3,5 30 2 5 0.0 3.5 N/D MAS, reduced bivent fxn. 9 h
8 3.0 40 9,9 30 16 2 1.3 3.2 20 h Sepsis, reduced bivent fxn 3 d
9 1.4 28 5,6 30 4 3 1.4 2.5 N/D RDS, sepsis 10 h
10 2.9 39 7,7 30 5 6 1.3 3.8 11 h Seizure, renal failure 10 d
11 1.7 32 6,7 60 8 3 1.3 2.2 19 h Sepsis 25 d
12 2.5 38 5,6 60 2 5 1.2 5.0 13 h Seizure, IVH, reduced bivent fxn 3 d
Median 2.7 37 45 7 4 1.3 4 17.5 h 3.5 d
DIC 5 disseminated intravascular coagulopathy, Gest 5 gestational, IVH 5 intraventricular hemorrhage, MAS 5 meconium aspiration syndrome, N/D 5 not
done, NEC 5 necrotizing enterocolitis, PPHN 5 persistent pulmonary hypertension of the newborn, RDS 5 respiratory distress syndrome, bivent fxn 5 biventricualr
function.
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patients were considered too small (1300 and 1400 g) for BAS
at the time and two patients (one with a completely intact atrial
septum) were considered so profoundly damaged by hypox-
emia and low cardiac output that it was elected not to pursue
further aggressive management. They both died within 2 h of
admission.
All 12 patients received supportive therapy prior to and
during transportation with 5–15 mg/kg/min of dopamine, me-
chanical ventilation to abolish respiratory acidosis if possible,
supplemental oxygen, and treatment of metabolic acidosis with
fluid and sodium bicarbonate. In addition, hypoglycemia,
hypocalcemia, and hypothermia were corrected. All patients
were paralyzed and sedated. On admission and after confir-
mation of diagnosis and associated medical problems therapy
was tailored accordingly. No patient received inhaled nitric
oxide therapy or mechanical support of the circulation preop-
eratively.
Associated medical problems (Table 1). Associated medi-
cal problems indicative of perinatal stress were frequent and
included respiratory distress syndrome, pulmonary hyperten-
sion, sepsis, and neurological injury (intraventricular and ce-
rebral hemorrhage, and seizure activity). In contrast, addi-
tional congenital malformations were uncommon. One patient
had congenital tracheal stenosis with complete cartilagenous
rings.
Prematurity and low birth weight. Between 1988 and 1996
we admitted nine patients with TGA and prematurity (3.05%
of TGA) and low, but appropriate, birth weight (,2 kg) for
gestational age. Four (three with TGA/intact ventricular sep-
tum [IVS] and one with TGA ventricular septal defect [VSD]
and coarctation of the aorta) underwent arterial switch oper-
ation, performed in three with TGA/IVS between days 3 and 8
of life and on day 43 in the patient with TGA/VSD after prior
coarctation repair and pulmonary artery band on day 12 of life,
without surgical mortality. Five patients who were managed
expectantly died prior to surgery. Comparison of group 1
(death before operation) versus group 2 (survival to surgery)
demonstrated no statistical difference in gestational age (p 5
0.14) or birth weight (p 5 0.14). However, group 2 had a
statistically significant higher initial oxygen saturation (p 5
0.04), larger atrial communication (p 5 0.01), and better
response to prostaglandin infusion (p 5 0.03).
Autopsy data. Autopsies were performed in six of 12 cases
(patients 1, 2, 3, 4, 6, and 8). All had PDA (median size
5.5 mm, range 4–8 mm). A restrictive PFO was found in all
patients who did not undergo BAS. Additional autopsy find-
ings were pulmonary hypertension (thickening of intima and
media of pulmonary arteries in two of six), disseminated
intravascular coagulopathy (fibrin platelet microthrombi in
pulmonary vessels in two of six), pulmonary hemorrhage (two
of six), and intracranial hemorrhage (four of six). Patient No.
5 had a perforation of the trachea following surgery for
congenital tracheal stenosis.
Comparison with survivors to ASO. We identified eight
neonates with TGA and a PFO #2 mm who survived to ASO
after BAS. All had TGA with IVS. They had significantly
higher oxygen saturations after infusion of PGE1 (median
68%, range 35–80 vs median 50%, range 30–70, p 5 0.03),
wider PFO (median 1.9 mm, range 1.4–2.0 vs median 1.3,
range 0–2.0, p 5 0.003), larger PDA (median 4.5 mm, range
3.5–5.8 vs median 3.5, range 2.2–5.0, p 5 0.01) and shorter
transport times (median 0.6 h, range 0.2–5 vs median 3.5 h,
range 2–6, p 5 0.004). There was no statistical difference
between birthweight (median 3200 g, range 2830–3700 vs
median 2720 g, range 1300–3800, p 5 0.2) but the gestational
age was older (median 40 wk, range 38–42 vs median 39 wk,
range 28–39, p 5 0.001). There were no statistical differences
in oxygen saturations before infusion of PGE1 (median 45%,
range 20–70 vs median 55%, range 25–72, p 5 0.33) or age that
PGE1 was started (median 3.8 h, range 1–13.7 vs median 7 h,
range 2–48, p 5 0.14) or age at BAS (median 15.5 h, range
5–20 vs median 17.5 h, range 11–192 p 5 0.31).
None of the eight patients developed metabolic sequelae of
hypoxemia (acidosis, hypoglycemia, or hypocalcemia) and only
two of eight required inotropic support (5 mg/kg/min dopa-
mine).
The shunt through the PDA was predominantly from aorta
to pulmonary artery in all patients as described by Baylen et al
(7). In contrast two of 12 nonsurvivors had bidirectional shunts
with right to left shunting throughout systole and into diastole.
BAS was performed in the cardiac catheterization laboratory
in four of eight and on the intensive care unit in four of eight.
Discussion
As the surgical results for the ASO continue to improve and
operative mortality falls below 3%, strategies to salvage pa-
tients at risk of death before surgery are of paramount
importance to reduce the overall mortality of TGA (8).
Although death before operation was recognized as an impor-
tant disadvantage of atrial redirection surgery for TGA (a
mortality of 11%), there is a paucity of information regarding
very early death in babies with TGA since the shift in manage-
ment to neonatal arterial switch surgery (4,6,9). Our study
demonstrates that death before surgery is substantial, espe-
cially when it is compared with the excellent short and long-
term survival with the arterial switch procedure (8,10). The
preoperative mortality rate in the present study is comparable
with the 3.7% (35/946 neonates with TGA admitted under 15
days of age) reported by Kirklin et al. (8). However, preoper-
ative attrition rates have improved from 16% of all transposi-
tions between 1979 and 1983 reported by Gilljam and 11% of
simple transpositions between 1976 and 1983 reported by
Trusler et al (6,11). In addition, we suggest that hypoxemia and
its sequelae, especially if the PFO is restrictive, the need for
transport to a cardiac center, the lack of response to PGE1,
low birthweight, and prematurity are important contributors to
preoperative mortality. Extracardiac anomalies are rare in
TGA and resulted in one death in our series prior to operation
(1,3). Therefore, strategies to improve overall survival should
examine earlier diagnosis and balloon atrial septostomy, as
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well as the influence of prematurity, low birth weight, and
pulmonary hypertension in more detail.
Earlier diagnosis. All patients who died required more
aggressive supportive therapy prior to transport and had
significantly longer transport times compared with survivors. In
addition, eight patients in our study died despite BAS, suggest-
ing that for some neonates there is a window of time within
which an atrial septostomy must be performed to avoid
permanent organ damage and death. This will require an
emphasis on prenatal screening and timely transport of the
mother to a tertiary care center before delivery. In the unusual
case when the diagnosis is made by echocardiography at the
referral center, it may be prudent to send a cardiologist to
perform a BAS prior to transportation, especially if there is
minimal improvement in systemic oxygen saturations with an
infusion of prostaglandin or evidence of important restriction
to interatrial mixing by echocardiography. However, we have
experience with a term baby with TGA/IVS, a restrictive PFO,
and PDA diagnosed prenatally who died in the delivery room
(12). It is notable that in the NERICP report by Fyler et al, five
of 236 patients with TGA presented at autopsy without prior
cardiac catheterization and Trusler et al noted three neonates,
moribund on admission, who died within a few hours of birth
(1,6). Therefore, there may be a subset of patients with
TGA/IVS with tenuous intercirculatory mixing in utero who
may be salvageable only by immediate BAS, perhaps even in
the delivery room and prior to separating the umbilical cord or
immediate cannulation for mechanical cardiopulmonary sup-
port.
While many patients with TGA benefit from PGE1 to
increase ductal flow, left atrial blood return, and mixing at
atrial level, paradoxically, those with restrictive atrial commu-
nications may become more cyanosed as left atrial hyperten-
sion closes further the flap of the foramen ovale, decreases
atrial mixing, reduces effective pulmonary flow, and results in
pulmonary edema (7). Prostaglandin infusion, prior to BAS,
was unsuccessful in improving oxygen saturation in most of our
patients who died. In contrast, survivors to ASO with a small
PFO responded with a significantly higher oxygen saturation.
Failure to respond to PGE1 infusion should alert all concerned
that rapid transport and BAS may be required. The impor-
tance of adequate intercirculatory mixing is emphasized by the
observation that all preoperative deaths occurred in patients
with an intact ventricular septum.
Prematurity and low birth weight. Prematurity is uncom-
mon in TGA (3). We found an incidence of 3.05%. The size of
the native atrial communication, an increase in oxygen satura-
tion in response to prostaglandin, and early ASO differentiated
those who survived from those who died. Indeed, the con-
founding management problems of low birth weight and
prematurity may be simplified if surgical corrections of anat-
omy and physiology are undertaken. Continued technical and
surgical advances, and our experience, suggest that the low
birthweight and premature neonate with congenital heart
disease may fare better with early correction rather than
prolonged medical supportive management waiting for growth
(13,14).
Associated medical problems. The associated medical
problems that complicated management (meconium aspiration
syndrome and persistent pulmonary hypertension) were indic-
ative of perinatal stress. The exact incidence of prenatal
restriction at ductal or atrial level that may compromise the
newborn with TGA and lead to rapid and critical hypoxemia
shortly after umbilical cord clamping remains unknown. How-
ever, our recent experience suggests that it may occur (12).
Improvements in fetal surveillance with prenatal transfer of
at-risk mother and fetus to a tertiary care center with facilities
for early BAS will be required.
Persistent pulmonary hypertension. Persistent hypoxemia,
especially in the upper body, after BAS and despite prosta-
glandin infusion may be due to persistent pulmonary hyper-
tension of the newborn complicating TGA (15,16). Recent
reports suggest that a brief period of stabilization, alkaliniza-
tion, and early ASO, with inhaled nitric oxide therapy pre and
postoperatively may be a successful strategy to salvage this
subgroup of neonates with TGA (16–18). Inhaled nitric oxide
therapy improves oxygenation in neonates with persistent
pulmonary hypertension of the newborn (PPHN) (19) and has
been useful in TGA/IVS and PPHN with predominant right to
left shunting at ductal level and hypoxemia despite BAS (17).
In refractory cases and especially if there is ventricular dys-
function, the use of extracorporeal cardiopulmonary support
may be lifesaving as reported by Luciani et al (17), although
the high incidence of cerebral hemorrhage may limit the use of
mechanical cardiopulmonary support. However, despite the
neonatal arterial switch, patients with TGA may develop
pulmonary vascular disease (20) and the presence of irrevers-
ible pulmonary vascular changes at birth may limit the efficacy
of therapy in some cases.
Conclusion. We found that 4.1% of neonates with TGA
died before surgery. In 11 of 12 patients death was due to
consequences of inadequate interatrial mixing despite prosta-
glandin infusion. Earlier diagnosis and balloon atrial septos-
tomy are critically important in determining survival. We
suggest that, in the neonate with TGA/IVS, failure to respond
to PGE1 infusion defines a patient with inadequate atrial
mixing who should be urgently and rapidly transferred for
immediate BAS. Even with prenatal diagnosis of TGA/IVS,
prediction of postnatal instability may be difficult. Therefore,
we suggest that prenatal diagnosis of TGA/IVS be accompa-
nied by delivery in a high-risk obstetrical unit with adjoining
facilities for immediate balloon atrial septostomy, and, if
necessary, supportive treatment of PPHN and ventricular
failure (including inhaled nitric oxide and mechanical cardio-
pulmonary support), to salvage this group of patients.
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